PharmaVoice 2026年2月12日 Lilly’s $2.4B bet on off-the-shelf cell therapy is part of a wider Big Pharma shift
PharmaVoice 2026年1月14日 Lilly, Novo test direct-to-employer approach that could cut out PBMs and lower costs
PharmaVoice 2025年11月24日 Eli Lilly becomes first drugmaker to hit $1 trillion in market value #Eli Lilly #drugmaking peers